IRF8 and lung carcinoma: Identifying new master transcriptional regulators of myeloid cell differentiation and investigating the role of known interferon regulatory factor 8 (IRF8), transcriptional factor for DC differentiation, can help control systemic tumor‐induced immunosuppression in lung cancer (Fig. 7B).